Activity of matrix metalloproteinases 1, 9, 19 tissue inhibitor 1 in the structural components of a nephron in rats with a destructive-inflammatory process in the urinary system
https://doi.org/10.21626/vestnik/2024-2/06
EDN: QEKKWE
About the Authors
Lyudmila N. RogovaRussian Federation
Oksana S. Filonenko
Russian Federation
Rodion A. Kudrin
Russian Federation
Victoria N. Povetkina
Russian Federation
Danil S. Lipov
Russian Federation
References
1. Page-McCaw A., Ewald A. J., Werb Z. Matrix metalloproteinases and the regulation of tissue remodeling. Nat Rev Mol Cell Biol. 2007;8(3):221-233. DOI: 10.1038/nrm2125.
2. Bashirova Z.R. Clinical and prognostic value of proteolysis factors in children with autosomal dominant polycystic kidney disease. Nefrologiya. 2019;23(2):91-99 (in Russ.). DOI: 10.24884/1561-6274-2019-23-2-91-99. EDN: OLXKQS.
3. Pereza N., Ostojić S., Volk M., Kapović M., Peterlin B. Matrix metalloproteinases 1, 2, 3 and 9 functional single-nucleotide polymorphisms in idiopathic recurrent spontaneous abortion. Reprod Biomed Online. 2012;24(5):567-575. DOI: 10.1016/j.rbmo.2012.01.008.
4. Zhao J., Wang L., Cao A., Jiang M., Chen X., Peng W. Renal Tubulointerstitial Fibrosis: A Review in Animal Models. Journal of integrative Nephrology and Andrology. 2015;2(3):75-80. DOI: 10.4103/2225-1243.161428.
5. Docherty M-H., O’Sullivan E.D., Bonventre J.V., Ferenbach D.A. Cellular Senescence in the Kidney. American Society of Nephrology. 2019;30(5):726-736. DOI: 10.1681/ASN.2018121251.
6. Grigoryeva I.M., Ragino Yu.I. The role of matrix metalloproteinases and some cytokines in the development of pancreas fibrosis. Sovremennaya gastroenterologiya. 2013;(5):16-20 (in Russ.). EDN: RWGJWN.
7. Hunter R.W., Bailey M.A. Hyperkalemia: pathophysiology, risk factors and consequences. Nephrol Dial Transplant. 2019;34(Suppl 3):iii2-iii11. DOI: 10.1093/ndt/gfz206.
8. Yarmolinskaya M.I., Molotkov A.S., Denisova V.M. Matrix metaloproteinases and inhibitors : clasification, mechanism of action. Journal of obstetrics and womans diseases. 2012;10(1):113-125 (in Russ.). EDN: PAIYTX.
9. Коржевский Д.Э., 2005; Полянцев А.А. с соавт., 2011; PanJian-weietal., 2005. С.65-69.
10. Trisvetova E.L. Magnesium homeostasis and aging. Meditsinskie novosti. 2018;281(2):45-50 (in Russ.). EDN: YRESFY.
11. Chen S., Fu H., Wu S., Zhu W., Liao J., Hong X., Miao J., Luo C., et al. Tenascin-C protects against acute kidney injury by recruiting Wnt ligands. Kidney Int. 2019;95(1):62-74. DOI: 10.1016/j.kint.2018.08.029.
12. Krutova A.S., Luchaninova V.N., Semeshina O.V., Nee A., Bykova O.G. The role of matrix metalloproteinases and their inhibitors in physiopathological processes in children with kidney disease. Pacific medical journal. 2020;1(79):11-15 (in Russ.). DOI: 10.34215/1609-1175-2020-1-11-15. EDN: ESWLHS.
13. Osipova N.A., Niauri D.A., Gzgzyan A.M., Emanuel V.L. Нефрология. 2017;21(1):73-79 (in Russ.). EDN: XVGWWF.
Review
For citations:
Rogova L.N., Filonenko O.S., Kudrin R.A., Povetkina V.N., Lipov D.S. Activity of matrix metalloproteinases 1, 9, 19 tissue inhibitor 1 in the structural components of a nephron in rats with a destructive-inflammatory process in the urinary system. Humans and their health. 2024;27(2):47-53. (In Russ.) https://doi.org/10.21626/vestnik/2024-2/06. EDN: QEKKWE